Taro Pharmaceutical Industries Ltd (NYSE:TARO)

99.86
Delayed Data
As of Nov 16
 0.00 / 0.00%
Today’s Change
93.01
Today|||52-Week Range
121.23
-4.63%
Year-to-Date

Today’s Trading

Previous close99.86
Today’s open99.34
Day’s range99.34 - 100.27
Volume10
Average volume (3 months)42,366
Market cap$3.9B
Data as of 4:02pm ET, 11/16/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+45.16%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-24.73%
P/E ratio16.8
Price/Sales5.99
Price/Book1.79

Competitors

 Today’s
change
Today’s
% change
AGIOAgios Pharmaceutical...-0.61-0.88%
GWPHGW Pharmaceuticals P...-0.01-0.01%
HZNPHorizon Pharma PLC-0.06-0.27%
HCMHutchison China Medi...+0.36+1.19%
Data as of 9:36am ET, 11/19/2018

Financials

Next reporting dateFebruary 6, 2019
EPS forecast (this quarter)$2.15
Annual revenue (last year)$661.9M
Annual profit (last year)$211.2M
Net profit margin31.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Uday Vijaykumar Baldota
Vice President &
Head-Operations
Itamar Karsenti
Corporate headquarters
Haifa Bay, Haifa

Forecasts